The DSM is the reference used by clinicians, researchers, and insurers to diagnose and classify mental disorders, with the intent to provide specific, objective criteria by which to assess symptoms and determine whether to pay for treatment. The American Psychiatric Association released the manual’s fifth edition in May 2013, nearly twenty years after the fourth…
We hosted this book talk and panel discussion for Professor Frances Kamm’s latest book, Bioethical Prescriptions: To Create, End, Choose, and Improve Lives (Oxford University Press, December 2013). The book showcased Professor Kamm’s articles on bioethics as parts of a coherent whole, with sections devoted to death and dying; early life (on conception and use…
Agenda 8:30 – 9:00am: Registration 9:00 – 9:05am: Welcome remarks 9:05 – 9:50am: Keynote 9:50 – 10:40am: Panel 1 – FSMA and Risk Regulation Strategy 10:40 – 11:00am: Break 11:00am – 12:15pm: Panel 2 – Regulating Farm Production: From Zero to Sixty 12:15 – 1:30pm: Lunch Break 1:30 – 2:45: Panel 3 – Benefits, Challenges,…
In the pharmaceutical industry, patents are the preeminent incentive for innovation in developing new drugs. But patents aren’t the whole story; regulatory agencies also offer different forms of exclusivity—enforced by the agencies themselves—to encourage different forms of innovation in the industry. This panel discussed actual and potential roles for those rewards in the context of…
Presentation Professor Cohen’s papers, “What (if anything) is Wrong with Human Enhancement? What (if anything) is Right With It?” and “This Is Your Brain On Human Rights: Moral Enhancement and Human Rights,” are now available by request. Please contact Kaitlin Burroughs at kburroughs@law.harvard.edu to receive copies. About the Presenter I. Glenn Cohen is a Professor…
Presentation Download Professor Outterson’s paper: “New Business Models for Sustainable Antibiotics.” About the Presenter Kevin Outterson is a Professor of Law and the Professor of Health Law, Bioethics, and Human Rights at Boston University. Professor Outterson teaches health law and corporate law, and his interests include global pharmaceutical markets, finance and organization of health care…
At our second Annual Health Law Year in P/Review event, the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School and the New England Journal of Medicine welcomed experts discussing major developments during 2013 and what to watch out for in areas including the Affordable Care Act, medical malpractice, FDA regulatory…
Imagine a rating or accreditation system for companies’ “global health footprint.” Such a system would rigorously assess companies’ overall impact on human health, including the health of the world’s poorest and sickest populations, then disseminate this information in ways that users could readily understand and act upon. If successful, such a system would inform and…
Presentation Professor Roberts’s readings, “Scaling Cost-Sharing to Wages” and “A Presumption against Expensive Healthcare Consumption,” are not available online. Please email Kaitlin Burroughs at kburroughs@law.harvard.edu to request copies. About the Presenter Christopher Robertson is an associate professor at the James E. Rogers College of Law, University of Arizona and an associate with the Safra Center…
The Conference honors Dan Brock and his contributions to bioethics. Brock has been one of the most influential figures in American bioethics. Prior to his arrival at Harvard, Dr. Brock was Senior Scientist and a member of the Department of Clinical Bioethics at the National Institutes of Health. Until July 2002, he was Charles C.…
